SEC Info - Intrexon Corp - ‘305B2’ on 6/29/18

SEC Info℠

Home

Help

Please Sign In

Intrexon Corp – ‘305B2’ on 6/29/18 – ‘EX-7’

On: Friday, 6/29/18, at 12:23pm ET · Effective: 6/29/18 · Accession #: 1193125-18-208998 · File #: 333-220326

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/29/18  Intrexon Corp                     305B2       6/29/18    2:52K                                    Donnelley … Solutions/FA

Statement of Eligibility by a Corporation Designated to Act as Trustee — Form T-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 305B2       Statement of Eligibility by a Corporation           HTML     17K 
                          Designated to Act as Trustee                           
 2: EX-7        Letter re: Non-Reliance upon a Previously Issued    HTML     20K 
                          Audit Report or Completed Interim Review

EX-7 — Letter re: Non-Reliance upon a Previously Issued Audit Report or Completed Interim Review

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-7

EXHIBIT 7

Consolidated Report of Condition of

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

of 400 South Hope Street, Suite 500, Los Angeles, CA 90071

At the close of business March 31, 2018, published in accordance with Federal regulatory authority instructions.


	Dollar amounts in thousands
ASSETS

Cash and balances due from depository institutions:
Noninterest-bearing balances and currency and coin		3,649
Interest-bearing balances		432,247
Securities:
Held-to-maturity securities		0
Available-for-sale securities		593,024
Equity securities with readily determinable fair values not held for trading		0
Federal funds sold and securities purchased under agreements to resell:
Federal funds sold		0
Securities purchased under agreements to resell		0
Loans and lease financing receivables:
Loans and leases held for sale		0
Loans and leases, held for investment		0
LESS: Allowance for loan and lease losses		0
Loans and leases held for investment, net of allowance		0
Trading assets		0
Premises and fixed assets (including capitalized leases)		10,325
Other real estate owned		0
Investments in unconsolidated subsidiaries and associated companies		0
Direct and indirect investments in real estate ventures		0
Intangible assets:
Goodwill		856,313
Other intangible assets		17,729
Other assets		123,432

Total assets	$	2,036,719


LIABILITIES

Deposits:
In domestic offices			731
Noninterest-bearing			731
Interest-bearing			0
Not applicable
Federal funds purchased and securities sold under agreements to repurchase:
Federal funds purchased			0
Securities sold under agreements to repurchase			0
Trading liabilities			0
Other borrowed money:
(includes mortgage indebtedness and obligations under capitalized leases)			0
Not applicable
Not applicable
Subordinated notes and debentures			0
Other liabilities			226,421
Total liabilities			227,152
Not applicable

EQUITY CAPITAL

Perpetual preferred stock and related surplus			0
Common stock			1,000
Surplus (exclude all surplus related to preferred stock)			1,123,298
Not available
Retained earnings			687,782
Accumulated other comprehensive income			-2,513
Other equity capital components			0
Not available
Total bank equity capital			1,809,567
Noncontrolling (minority) interests in consolidated subsidiaries			0
Total equity capital			1,809,567

Total liabilities and equity capital			2,036,719

I, Matthew J. McNulty, CFO of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

Matthew J. McNulty ) CFO

We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

Antonio I. Portuondo, President )

William D. Lindelof, Director ) Directors (Trustees)

Alphonse J. Briand, Director )

Dates Referenced Herein and Documents Incorporated by Reference

This ‘305B2’ Filing	Date	Other Filings

Filed on / Effective on:	6/29/18	FWP
	3/31/18	10-Q, 8-K
		List all Filings

↑Top